X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

HARP

Closed

Harpoon Therapeutics Inc

23.01
0.00 (0.00%)
Last Update: 11 Mar 2024 23:00:00
Yesterday: 23.01
Day's Range: 22.99 - 23.02
Send
When Written:
 
0.75
Harpoon Therapeutics Inc. is a clinical-stage immunotherapy company that develops novel T cell engaging biologics for the treatment of cancer and other diseases. The company's proprietary Tri-specific T cell Activating Construct (TriTAC) platform harnesses the power of the immune system to selectively target and kill cancer cells while sparing healthy cells. Harpoon's lead product candidate, HPN424, is being developed for the treatment of prostate cancer and is currently in Phase 1 clinical trials. The company is also developing multiple other TriTAC product candidates for the treatment of solid tumors and hematologic malignancies. Harpoon Therapeutics was founded in 2015 and is headquartered in South San Francisco, California.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X